TriArm Therapeutics
Beijing
About TriArm Therapeutics
TriArm Therapeutics is a cell therapy company formed by Panacea Venture with R&D operations in Germany, United States and Greater China region. The company focuses on the research and clinical transformation of CD19 CAR-T product using non-viral gene transfer technology, which greatly reduces the cost and time of cell therapy product preparation, enabling better tumor therapy outcome.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $80.0M
- Last round: Series Unknown (Sep 2021)
- Website: triarmbio.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/triarm-therapeutics-29430 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.